Pancreatic Cancer - Pipeline Insights, 2016DelveInsight, the leading market research and consulting company has added new report Pancreatic Cancer - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight.
By: DelveInsight Business Reseacrh • In-depth analysis of the pipeline assets across this indication. • Insights on 15+ products with 10+ companies which are active in this field. • R&D activities and technologies used along with the pipeline molecules in development. • Information related to collaborations, in-licensing and out-licensing deals. • Stages of development of pipeline molecules. • Therapeutic assessments by molecule types, route of administration, monotherapy and combination products. • Highlights the discontinued and inactive projects in pipeline. Pancreatic Cancer - Pipeline Insights, 2016 Report envisages Pipeline Intelligence by identifying the key players along with their potential pipeline molecule. Therefore DelveInsight's report on Pancreatic Cancer helps to optimize portfolio by creating effective counter-strategies to gain competitive and therapeutic advantage in global Pharma market. In addition, it assesses the major market drivers and barriers in development of Pipeline molecules which helps to understand market for collaborations and licensing deals. DelveInsight is offering the Report at a price of USD 2250 as a single user license, USD 4500 as a site license and USD 6750 as a Global/Enterprise License. For more information on Pipeline Insight Reports,visit http://www.delveinsight.com or email at info@delveInsight.com About Us: DelveInsight is a leading Business Consulting and Market Research Firm. We help our clients to find answers relevant to their business, facilitating decision-making; End
|
|
Account Phone Number